In addition, some studies uncovered that the known immunosuppressive effects of the anti-TNF-α drugs provide a predisposition of patients with RA and CD to lymphoma, although a causal relationship between them still cannot be established [11–13]. The gene discussed is TNF; the disease is rheumatoid arthritis.